相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of cannabidiol in anxiety and anxiety-related disorders
Jessica W. Skelley et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2020)
Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies
Suhas Ganesh et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson's disease
Luba Smolensky et al.
SCIENTIFIC DATA (2020)
Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment
L. Cinnamon Bidwell et al.
JAMA PSYCHIATRY (2020)
Cannabinoids, Endocannabinoids and Sleep
Andrew J. Kesner et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
Lara Sharpe et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study
Maureen A. Leehey et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
Guy Hindley et al.
LANCET PSYCHIATRY (2020)
Qualitative Analysis of Cannabis Use Among Older Adults in Colorado
Julie Bobitt et al.
DRUGS & AGING (2019)
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
Abigail M. Freeman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations
Marco Echeverria-Villalobos et al.
JOURNAL OF CLINICAL ANESTHESIA (2019)
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
Nadia Solowij et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal
Laura Weinkle et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Disturbances of postural sway components in cannabis users
Amanda R. Bolbecker et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Practical considerations in medical cannabis administration and dosing
Caroline A. MacCallum et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure
Marco Colizzi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Cannabis consumption and psychosis or schizophrenia development
Maria Bettina Ortiz-Medina et al.
INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY (2018)
Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation
John H. Kindred et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2017)
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
Ryan Vandrey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
Sabrina Giacoppo et al.
MOLECULES (2014)
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
Alejandro Aparisi Rey et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
Cannabidiol for the treatment of psychosis in Parkinson's disease
A. W. Zuardi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
Barth Wilsey et al.
JOURNAL OF PAIN (2008)
分享论文
